Acura Pharmaceuticals is engaged in the development and commercialization of abuse-deterrent products.
Business Model:
Revenue: $2.2M
Employees: 11-50
Address: 616 N. North Court
City: Palatine
State: IL
Zip: 60067
Country: US
Acura Pharmaceuticals is engaged in the development and commercialization of abuse-deterrent products.
Contact Phone:
+18477057709
Contact Email:
Listed Exchange:
OTCMKTS
IPO Date:
2/23/2017
Ticker Symbol:
ACUR
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2013 | Post-IPO Debt | 1 | $10M |
Oxford Finance LLC Oxford Finance LLC Oxford Finance LLC Oxford Finance LLC |
2/2017 | Secondary Offering | $5M | 8/2014 | Grant | - | 1/2014 | Debt | $10M |
Oxford Finance LLC |
4/2020 | Debt | $150k |
U.S. Small Business Administration. |
7/2017 | Private Placement | $4M | 8/2014 | Grant | $300k | 8/2014 | Grant | - |
National Institutes of Health National Institutes of Health |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|